The chromatin-binding domain of Ki-67 together with p53 protects human chromosomes from mitotic damage
Author(s) -
Osama Garwain,
Xiaoming Sun,
Divya Iyer,
Rui Li,
Lihua Julie Zhu,
Paul D. Kaufman
Publication year - 2021
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.2021998118
Subject(s) - chromatin , mitosis , anaphase , dna damage , microbiology and biotechnology , g2 m dna damage checkpoint , biology , cell cycle checkpoint , cell cycle , micronucleus test , cell , chemistry , dna , genetics , organic chemistry , toxicity
Significance Ki-67 is a clinically important tumor proliferation marker protein. Ki-67 contributes to the three-dimensional organization of heterochromatin during interphase of the cell cycle, and also coats and shapes condensed chromosomes during mitosis. Here, we show that acute depletion of Ki-67 in human cells causes DNA damage as cells traverse mitosis. When the tumor suppressor protein p53 is codepleted with Ki-67, multiple hallmarks of genome instability arise, including anaphase chromosome bridges, followed by the appearance of micronuclei. The C-terminal chromatin-binding domain of Ki-67 is sufficient for resistance to this damage. These studies uncover a factor for genome maintenance and identify a protective protein domain.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom